Quince Therapeutics, Inc. (QNCX)
0.0903
-0.01
(-8.79%)
USD |
NASDAQ |
Apr 06, 13:37
Quince Therapeutics EPS Diluted (TTM) : -1.219 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -1.483 |
| Ocular Therapeutix, Inc. | -1.438 |
| Gossamer Bio, Inc. | -0.7499 |
| Ernexa Therapeutics, Inc. | -1.104 |
| Acurx Pharmaceuticals, Inc. | -3.892 |